The prevalence of glucocorticoid hypersecretion and the loss of hippocampal inhibition of hypothalamus-pituitary-adrenal (HPA) axis in Alzheimer type dementia (ATD) underlie the 'glucocorticoid cascade' hypothesis for a neuroendocrine definition of aging. Therefore we measured, in mild to moderate demented patients, plasma B-endorphin and cortisol levels, which, in 41% of the subjects were both higher than 2 SD of mean control values. The treatment with Acetyl-L-Carnitine (ALC) normalized the highest values, while piracetam did not. The possibilities that this effect is due to the cholinergic activity of ALC and/or its action in preventing the loss of hippocampal glucocorticoid receptors after cold stress are suggested
The simultaneous evaluation of the circadian rhythm of plasma melatonin and ACTH and of serum cortis...
Valutazione delle performance cognitive in una popolazione di pazienti con malattia di Alzheimer in ...
The responsibility of cerebral cholinergic lesions for the weak clinical response to cholinergic neu...
The prevalence of glucocorticoid hypersecretion and the loss of hippocampal inhibition of hypothalam...
Acetyl-L-carnitine (ALCAR) is a drug currently under investigation for Alzheimer disease (AD) therap...
Brain autoradiography in adrenalectomized rats injected with 3H-corticosterone 2 hr before sacrifice...
Meccanismi neuroendocrini (iperattività dell'asse HPA) sottesi allo sviluppo della demenza degenerat...
Studio in doppio cieco sugli effetti neuroendocrini e cognitivi di un trattamento con L-acetilcarnit...
Acetyl-L-carnitine acutely administered raises beta-endorphin and cortisol plasma levels in humans
Several studies explored the effects of acetyl-L-carnitine (ALC) in dementia, suggesting a role in s...
Dysfunction of the limbic-hypothalamic-pituitary-adrenal (LHPA) axis is a common finding in advanced...
Functional hypothalamic amenorrhea (FHA) is a relatively frequent disease due to the combination of ...
15 demented patients aged 56-71 years, who underwent a therapeutic trial with DL or L acetyl carniti...
The aim of the present study was to investigate the neuronal structure sthat mediate the Antiaging ...
The pineal and pituitary-adrenocortical secretions play an important role in adaptive responses of t...
The simultaneous evaluation of the circadian rhythm of plasma melatonin and ACTH and of serum cortis...
Valutazione delle performance cognitive in una popolazione di pazienti con malattia di Alzheimer in ...
The responsibility of cerebral cholinergic lesions for the weak clinical response to cholinergic neu...
The prevalence of glucocorticoid hypersecretion and the loss of hippocampal inhibition of hypothalam...
Acetyl-L-carnitine (ALCAR) is a drug currently under investigation for Alzheimer disease (AD) therap...
Brain autoradiography in adrenalectomized rats injected with 3H-corticosterone 2 hr before sacrifice...
Meccanismi neuroendocrini (iperattività dell'asse HPA) sottesi allo sviluppo della demenza degenerat...
Studio in doppio cieco sugli effetti neuroendocrini e cognitivi di un trattamento con L-acetilcarnit...
Acetyl-L-carnitine acutely administered raises beta-endorphin and cortisol plasma levels in humans
Several studies explored the effects of acetyl-L-carnitine (ALC) in dementia, suggesting a role in s...
Dysfunction of the limbic-hypothalamic-pituitary-adrenal (LHPA) axis is a common finding in advanced...
Functional hypothalamic amenorrhea (FHA) is a relatively frequent disease due to the combination of ...
15 demented patients aged 56-71 years, who underwent a therapeutic trial with DL or L acetyl carniti...
The aim of the present study was to investigate the neuronal structure sthat mediate the Antiaging ...
The pineal and pituitary-adrenocortical secretions play an important role in adaptive responses of t...
The simultaneous evaluation of the circadian rhythm of plasma melatonin and ACTH and of serum cortis...
Valutazione delle performance cognitive in una popolazione di pazienti con malattia di Alzheimer in ...
The responsibility of cerebral cholinergic lesions for the weak clinical response to cholinergic neu...